NCT06465082 Diaphragmatic Thickening Fraction as a Predictor of Successful Weaning
| NCT ID | NCT06465082 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mansoura University Hospital |
| Condition | Weaning From Mechanical Ventilation |
| Study Type | OBSERVATIONAL |
| Enrollment | 55 participants |
| Start Date | 2024-09-05 |
| Primary Completion | 2025-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 55 participants in total. It began in 2024-09-05 with a primary completion date of 2025-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to assess the validity of the diaphragmatic thickening Fraction measured by ultrasound as a predictor for successful weaning from mechanical ventilation.
Eligibility Criteria
Inclusion Criteria: * Adult patients \>18 years old, who are in need for mechanical ventilation as: Life threatening hypoxia, Respiratory rate \> 30 breath/min, Disturbed conscious level. Exclusion Criteria: * Age \<18 years. * Pregnancy * Surgical incisions likely to interfere with ultrasound examination. * Hepato-splenomegaly, Ascites * Neuromuscular disease as Myasthenia gravis, kypho-scoliosis * Diaphragmatic Paralysis (paralyzed diaphragm exhibiting abnormal paradoxical movement, i.e., moving in a cranial direction during inspiration
Contact & Investigator
Mohamed AbdElmoniem
PRINCIPAL INVESTIGATOR
Mansoura University
Frequently Asked Questions
Who can join the NCT06465082 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Weaning From Mechanical Ventilation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06465082 currently recruiting?
Yes, NCT06465082 is actively recruiting participants. Contact the research team at dr.m1993@mans.edu.eg for enrollment information.
Where is the NCT06465082 trial being conducted?
This trial is being conducted at Al Mansurah, Egypt.
Who is sponsoring the NCT06465082 clinical trial?
NCT06465082 is sponsored by Mansoura University Hospital. The principal investigator is Mohamed AbdElmoniem at Mansoura University. The trial plans to enroll 55 participants.